Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 5/20 | 0.45 |
| ▸ | CA2 | P00918 | 5/20 | 0.45 |
| ▸ | CA4 | P22748 | 5/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | PTGS1 | P23219 | 8/20 | 0.43 |
| ▸ | PTGS2 | P35354 | 8/20 | 0.43 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | CA6 | P23280 | 4/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20165714 | 1.00 | CA1 (0.45) | CA1CA2CA4KMT2APTGS1 | |
| SCHEMBL3731600 | 0.98 | KMT2A (0.47) | CA1CA2CA4KMT2APTGS1 | |
| SCHEMBL10818954 | 0.98 | KMT2A (0.47) | CA1CA2CA4KMT2APTGS1 | |
| SCHEMBL2691668 | 0.94 | PTGS1 (0.44) | CA1CA2CA4KMT2APTGS1 | |
| SCHEMBL2690043 | 0.85 | — | — | |
| SCHEMBL11904307 | 0.82 | CA1 (0.41) | CA1CA2CA4KMT2APTGS1 | |
| SCHEMBL3823777 | 0.82 | CA1 (0.45) | CA1CA2CA4KMT2APTGS1 | |
| SCHEMBL9943495 | 0.81 | CA1 (0.39) | CA1CA2CA4KMT2APTGS1 | |
| SCHEMBL1986958 | 0.80 | NPC1 (0.45) | CA1CA2CA4KMT2APTGS1 | |
| SCHEMBL4128734 | 0.80 | NOS1 (0.45) | CA1CA2CA4KMT2APTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 98 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119751266-A | 4- (2-Butyl) amino aniline and preparation method thereof | 滁州市庆云医药有限公司 | 2025-04-04 | — | — | CN | claimed |
| US-9290691-B2 | Organic el material-containing solution, method for forming organic el thin film, organic el device comprising organic el thin film, and method for manufacturing organic el display panel | IDEMITSU KOSAN CO., LTD. (JP) | 2016-03-22 | — | — | US | claimed |
| US-20120110900-A1 | Liquid fuel composition and method for enhancing combustion efficiency of a liquid fuel | TSAI KAI-SHON (TW) | 2012-05-10 | — | — | US | claimed |
| US-12590089-B2 | Processes for preparing toll-like receptor modulator compounds | GILEAD SCIENCES, INC. (US) | 2026-03-31 | — | — | US | disclosed |
| EP-4025675-B1 | A PERFUME OIL MIXTURE | SYMRISE AG (DE) | 2026-03-18 | — | — | EP | disclosed |
| US-12421474-B2 | Perfume oil mixture | SYMRISE AG (DE) | 2025-09-23 | — | — | US | disclosed |
| CN-119751266-A | 4- (2-Butyl) amino aniline and preparation method thereof | 滁州市庆云医药有限公司 | 2025-04-04 | — | — | CN | disclosed |
| US-20250066377-A1 | AMINO CHROMEN-2-ONE MODULATORS OF POLRMT | PRETZEL THERAPEUTICS, INC. (US) | 2025-02-27 | — | — | US | disclosed |
| CN-119371422-A | Methods for preparing Toll-like receptor modulator compounds | 吉利德科学公司 | 2025-01-28 | — | — | CN | disclosed |
| CN-114269744-B | Methods for preparing Toll-like receptor modulator compounds | 吉利德科学公司 | 2024-10-18 | — | — | CN | disclosed |
| US-20240229089-A1 | A process for enzymatic synthesis of amides from amines and carboxylic acids or esters | XP CHEMISTRIES AB (SE) | 2024-07-11 | — | — | US | disclosed |
| US-4517379-A | ARTIFICIAL SWEETENER | PFIZER INC. (US) | 1985-05-14 | — | — | US | disclosed |
| US-4499306-A | HALOGENATION OF 2-ISOBUTYLIDENE CYCLOHEXANONE IN PRESENCE OF CATALST | MITSUBISHI CHEMICAL INDUSTRIES LTD. (JP) | 1985-02-12 | — | — | US | disclosed |
| EP-0069811-B1 | BRANCHED AMIDES OF L-ASPARTYL-D-AMINO ACID DIPEPTIDES AND COMPOSITIONS THEREOF | PFIZER INC. (US) | 1984-10-24 | — | — | EP | disclosed |
| EP-0034876-B1 | BRANCHED AMIDES OF L-ASPARTYL-D-AMINO ACID DIPEPTIDES AND COMPOSITIONS THEREOF | PFIZER INC. (US) | 1984-08-29 | — | — | EP | disclosed |
| US-4454328-A | SWEETENERS | PFIZER INC. (US) | 1984-06-12 | — | — | US | disclosed |
| US-4411925-A | STABLE SWEETENERS | PFIZER INC. (US) | 1983-10-25 | — | — | US | disclosed |
| EP-0090976-A2 | 2,2-Dihalo-6-halo-6(1-haloisobutyl)cyclohexanone | MITSUBISHI KASEI CORPORATION (JP) | 1983-10-12 | — | — | EP | disclosed |
| US-4399163-A | ARTIFICIAL SWEETENERS | PFIZER INC. (US) | 1983-08-16 | — | — | US | disclosed |
| EP-0069811-A1 | Branched amides of L-aspartyl-D-amino acid dipeptides and compositions thereof | PFIZER INC. (US) | 1983-01-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12590089-B2 | Processes for preparing toll-like receptor modulator compounds | TLR8, MYD88, TLR6 | CA1 3650/4885CA2 1648/4885CA4 3897/4885 |
| US-20250066377-A1 | AMINO CHROMEN-2-ONE MODULATORS OF POLRMT | POLRMT, TFAM, POLM | CA1 4859/4885CA2 4380/4885CA4 4705/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.